Cancer Care Ontario | Cancer Care Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

21 Results

Guidelines and Advice

Standardized Endoscopy Reporting Guidelines

Status: Current

Jun 2021

Guidelines and Advice

Bowel Preparation Selection Best Practice Guidelines

Status: Current

Jun 2021

Guidelines and Advice

Standardized Patient Discharge Guidelines - Endoscopy/Colonoscopy

Status: Current

Jun 2021

Guidelines and Advice

Pandemic Planning Clinical Guideline for Patients with Cancer

Status: Current
Version: 2

Dec 2021

Guidelines and Advice

An Endorsement of the 2021 Guideline on Chemotherapy in Combination with Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline

Status: Current
ID: GL END 5-7
Version: 3

Nov 2021

Guidelines and Advice

Pre- and Post-Procedure Guidelines and Checklists - Endoscopy/Colonoscopy

Status: Current

Jun 2021

Guidelines and Advice

Prevention and Outpatient Management of Febrile Neutropenia in Adult Cancer Patients: Clinical Practice Guideline

Status: Current
ID: GL-C50-27

Nov 2021

Guidelines and Advice

Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines July to December 2020

Status: Current
ID: PET 2020-2

May 2021

Guidelines and Advice

Management of the Axilla in Early-Stage Breast Cancer: Ontario Health (Cancer Care Ontario) and the American Society of Clinical Oncology Joint Guideline

Status: Current
ID: GL 1-23-A

Jul 2021

Guidelines and Advice

Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: American Society of Clinical Oncology (ASCO) and Ontario Health (Cancer Care Ontario) Joint Guideline Update

Status: Current
ID: 7-A-2018-3

Feb 2021

Guidelines and Advice

Follow-up Care, Surveillance Protocols and Secondary Prevention Measures for Survivors of Colorectal Cancer

Status: Current
ID: GL 26-2
Version: 3

Mar 2021

Guidelines and Advice

Neoadjuvant and adjuvant systemic therapy for newly diagnosed stage II, III, or IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma

Status: Current
ID: GL 4-1
Version: 2

Jan 2021

Pages